These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


331 related items for PubMed ID: 31771047

  • 1. Downregulation of serum exosomal miR-216b predicts unfavorable prognosis in patients with non-small cell lung cancer.
    Liu W, Liu J, Zhang Q, Wei L.
    Cancer Biomark; 2020; 27(1):113-120. PubMed ID: 31771047
    [Abstract] [Full Text] [Related]

  • 2. Identification of Circulating miR-762 as a Novel Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer.
    Chen L, Li Y, Lu J.
    Technol Cancer Res Treat; 2020; 19():1533033820964222. PubMed ID: 33317398
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Diagnostic and Prognostic Value of the Combination of Tumor M2-Pyruvate Kinase, Carcinoembryonic Antigen, and Cytokeratin 19 Fragment in Non-Small Cell Lung Cancer.
    Li L, Xu Y, Wang Y, Zhang Q, Wang Y, Xu C.
    Technol Cancer Res Treat; 2024; 23():15330338241265983. PubMed ID: 39043046
    [Abstract] [Full Text] [Related]

  • 6. Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer.
    Zhang YL, Zhang ZL, Zhu XB, Xu L, Lu P, Xu M, Liu WJ, Zhang XY, Yao HM, Ye XW.
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5251-5259. PubMed ID: 31298376
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer.
    Sun B, Liu HF, Ding Y, Li Z.
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3061-3066. PubMed ID: 29863251
    [Abstract] [Full Text] [Related]

  • 11. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y, Zhang G, Li H, Han L, Fu A, Zhang N, Zheng Y.
    Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
    [Abstract] [Full Text] [Related]

  • 12. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q.
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [Abstract] [Full Text] [Related]

  • 13. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
    Guo W, Zhang Y, Zhang Y, Shi Y, Xi J, Fan H, Xu S.
    Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reduced serum exosomal miR-874 expression predicts poor prognosis in colorectal cancer.
    Zhang N, Zhang PP, Huang JJ, Wang ZY, Zhang ZH, Yuan JZ, Ma EM, Liu X, Bai J.
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):664-672. PubMed ID: 32016967
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL, Chen YL, Ge ZZ, Qu YY, Cao Y, Kang ZX.
    Cancer Biomark; 2019 Jan; 26(1):69-77. PubMed ID: 31306108
    [Abstract] [Full Text] [Related]

  • 17. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
    Jiang AG, Chen HL, Lu HY.
    BMC Cancer; 2015 May 10; 15():386. PubMed ID: 25956656
    [Abstract] [Full Text] [Related]

  • 18. Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer.
    Zhang W, Su X, Li S, Liu Z, Wang Q, Zeng H.
    Cancer Biomark; 2020 May 10; 27(4):485-491. PubMed ID: 32065786
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer.
    Kanaoka R, Iinuma H, Dejima H, Sakai T, Uehara H, Matsutani N, Kawamura M.
    Oncology; 2018 May 10; 94(5):311-323. PubMed ID: 29533963
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.